Cargando…

Long-term follow-up of patients with ATL after autologous stem cell transplantation

Detalles Bibliográficos
Autores principales:	Utsunomiya, Atae, Tokunaga, Masahito, Nakano, Nobuaki, Fujiwara, Hiroshi, Miyamoto, Toshihiro, Ogata, Masao, Miyazaki, Yasuhiko, Ishitsuka, Kenji, Sakaida, Emiko, Taji, Hirofumi, Wakayama, Toshio, Ichinohe, Tatsuo, Fukuda, Takahiro, Atsuta, Yoshiko, Kato, Koji, Yoshimitsu, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821007/ https://www.ncbi.nlm.nih.gov/pubmed/35066568 http://dx.doi.org/10.1038/s41409-021-01412-9

Ejemplares similares

Effect of a novel anti-CCR4 monoclonal antibody (Mogamulizmab) on skin lesions of adult T-cell leukemia-lymphoma (ATL) and its adverse skin reactions (ASR)
por: Yonekura, Kentaro, et al.
Publicado: (2014)

GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma
por: Muranushi, Hiroyuki, et al.
Publicado: (2020)

Sensitive detection and apoptotic cell death induction of adult T-cell leukemia/lymphoma (ATL) cells with photodynamic actions
por: Oka, Takashi, et al.
Publicado: (2014)

Disorders of the cMyb proto-oncogene expression and its significance in the course of ATL development
por: Nakano, Kazumi, et al.
Publicado: (2014)

Clinical landscape of TP73 structural variants in ATL patients
por: Hiramatsu, Hiroaki, et al.
Publicado: (2023)

Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
por: Utsunomiya, Atae, et al.
Publicado: (2015)

Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011)

Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study
por: Ito, Ayumu, et al.
Publicado: (2021)

Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma
por: HARAGUCHI, KOUICHI, et al.
Publicado: (2012)

Overexpression of aberrant Wnt5a and its effect on acquisition of malignant phenotypes in adult T-cell leukemia/lymphoma (ATL) cells
por: Nakano, Kazumi, et al.
Publicado: (2021)

Elderly ATL patients in ageing society of Japan
por: Takemoto, Shigeki, et al.
Publicado: (2011)

ATL internals: working with ATL 8
por: Tavares, Chris
Publicado: (2006)

Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
por: Yonekura, Kentro, et al.
Publicado: (2015)

The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes
por: Suehiro, Youko, et al.
Publicado: (2014)

ATL internals
por: Rector, Brent, et al.
Publicado: (1999)

ATL internals /
por: Rector, Brent
Publicado: (1999)

Dr. Atl /
por: Luna Arroyo, Antonio
Publicado: (1992)

Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014)

Dr. Atl : pinturas y dibujos /
por: Atl, Dr., 1875-1964
Publicado: (1974)

Identification of Genes Associated with the Progression of Adult T Cell Leukemia (ATL)
por: Kohno, Tomoko, et al.
Publicado: (2000)

High resolution lectin microarray system for the ATL cell-typing and the evaluation of anti-cancer efficacy of medications
por: Iha, Hidekatsu, et al.
Publicado: (2014)

Dr. Atl : el paisaje como pasión /
por: Espejo, Beatriz
Publicado: (1994)

A novel HSP90 inhibitor, 17-DMAG, induces Tax down-regulation and its oral administration to ATL-model mice intervenes against the infiltration property of the ATL-like lymphocytes and provides extended survival period
por: Ikebe, Emi, et al.
Publicado: (2014)

A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma
por: Ishitsuka, Kenji, et al.
Publicado: (2015)

Dr. Atl : paisaje de hielo y fuego /
por: Roura, Alma Lilia
Publicado: (1999)

Clinical Trials and Treatment of ATL
por: Tsukasaki, Kunihiro, et al.
Publicado: (2012)

Recent advances in the treatment of adult T-cell leukemia-lymphomas
por: Utsunomiya, Atae, et al.
Publicado: (2015)

Contralateral Pedicled Anterolateral Thigh Flap (ATL) for Upper Thigh Defect in the Era of Free ATL?
por: Hulika, Narendra, et al.
Publicado: (2016)

Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation
por: Iida, Minako, et al.
Publicado: (2020)

Presence of cutaneous lesion is a poor prognostic factor in patients with smoldering-type adult T-cell leukemia-lymphoma
por: Yonekura, Kentaro, et al.
Publicado: (2011)

Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab
por: Nosaka, Kisato, et al.
Publicado: (2021)

Gerardo Murillo, el Dr. Atl.
por: Casado Navarro, Arturo
Publicado: (1984)

ATLS(® )and damage control in spine trauma
por: Schmidt, Oliver I, et al.
Publicado: (2009)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

A new paradigm for the management of ATL
por: Taylor, Graham P., et al.
Publicado: (2022)

Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
por: Utsunomiya, Atae
Publicado: (2014)

Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
por: Utsunomiya, Atae
Publicado: (2019)

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL
por: Kannagi, Mari, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sckgtpmjo8fm75evuu39q940a2